With 12.86 million shares changed hands, the volume of the stock remained lighter than its average volume of 23.25 million shares. The 52-week range on HBAN shows that it touched its highest point at $18.44 and its lowest point at $11.91 during that stretch. It currently has a 1-year price target of $17.31. With its current market cap of 21.88 billion, HBAN has annualized dividend of $0.62 while the current yield stands at 4.13%. Beta for the stock currently stands at 0.94.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HBAN was up-trending over the past week, with a rise of 3.02%, but this was up by 11.59% over a month. Three-month performance dropped to -10.81% while six-month performance fell -4.57%. The stock gained 10.04% in the past year, while it has lost -7.68% so far this year. A look at the trailing 12-month EPS for HBAN yields 1.30 with Next year EPS estimates of 1.58. For the next quarter, that number is 0.36. This implies an EPS growth rate of 17.51% for this year and 10.02% for next year. EPS is expected to grow by 12.87% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -0.74%.
Float and Shares Shorts:
At present, 1.46 billion HBAN shares are outstanding with a float of 1.44 billion shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HBAN since 7 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $1.22363 being high and $1.19402 being low. For HBAN, this leads to a yearly average estimate of $1.20389.